Axcelead DDP’s Drug Discovery Support Business Honored with the 6th Japan Medical Research and Development Grand Prize
Axcelead Drug Discovery Partners Inc. (“Axcelead DDP”) is …
Accessing a Diverse and High-Quality Compound Library
Discovering effective drugs starts with finding promising hit compounds. Axcelead …
Success Factors for Drug Discovery Journey From the Ground Up
Axcelead’s integrated High-throughput Screening (HTS) platform plays a crucial role …
Integrated Plattform for Hit Identification ～Hit characterization in Post HTS～
At Axcelead, we specialize in post-High-Throughput Screening follow-up, a critical …
Integrated Platform for Hit Identification ～Hit expansion in Post HTS～
Discovering effective compounds through high-throughput screening is tough due to …
Integrated Platform for Hit Identification ～Phenotypic Drug Discovery～
Axcelead has two strengths in phenotypic drug discovery.
The first is …
Discussions Begin on Collaborative Genomic Drug Discovery Support Using the IQVIA Genome Wide Study Platform
Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa, Kanagawa; …
Luncheon seminar at the 43rd Workshop of the Korean Society of Nonclinical Study
Join us for our luncheon seminar and visit …